Eli Lilly's Kisunla wins FDA nod for new dosing with fewer side effects in Alzheimer's
- Leo Zini
- Jul 9
- 1 min read
top of page
Search
Recent Posts
See Allhttps://www.npr.org/sections/shots-health-news/2025/05/21/nx-s1-5403736/first-fda-alzheimers-blood-test-cleared-diagnosis
https://www.statnews.com/2025/05/16/alzheimers-fujirebio-fda-approval/
https://www.realclearhealth.com/articles/2024/11/27/polling_reveals_americans_back_alzheimers_patients_1074894.html
bottom of page